Lucio Luzzatto

University of Firenze

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Year:

2025

Year:

2025

Year:

2025

Early malaria investigators were certainly correct in classifying the species falciparum and the species vivax as belonging to the same genus, Plasmodium [...]

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Collaborators (3)

Shinji Nakao

JAPAN

View details

schuh Anna

University of Oxford

UNITED KINGDOM

View details

Alan J Warren

University of Cambridge

UNITED KINGDOM

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Lucio Luzzatto

Research Interests

Explore related searches

Contact this professor

Articles (18)

Novel ADAMTS13 Mutation in a Patient With Congenital TTP Diagnosed in Pregnancy

Pathogenesis of paroxysmal nocturnal hemoglobinuria

Globalization in clinical drug development for sickle cell disease

Plasmodium vivax Malaria and G6PD Testing

Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification

<i>Plasmodium vivax</i> Malaria and G6PD Testing

Closing remarks

Closing remarks

Genetic variants causing G6PD deficiency: Clinical and biochemical data support new WHO classification

Blood diseases in Africa: Redressing unjust disparities is an urgent unmet need

Management of paroxysmal nocturnal hemoglobinuria (PNH)

High incidence of malaria in patients with sickle cell disease

Breakthrough Hemolysis in PNH with Proximal or Terminal Complement Inhibition

Severe congenital neutropenia with elastase, neutrophil expressed (ELANE) gene mutation in a Tanzanian child

Blood diseases in Africa: Redressing unjust disparities is an urgent unmet need

Molecular response to imatinib in patients with chronic myeloid leukemia in Tanzania

Control of hemolysis in patients with PNH

Making hydroxyurea affordable for sickle cell disease in Tanzania is essential (HASTE): How to meet major health needs at a reasonable cost

Collaborators (3)

Shinji Nakao

schuh Anna

Alan J Warren

Make your next move.